---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-046326"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2022-08-10T23:59:59+00:00"
generated_at: "2026-06-24T01:40:22.990541+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Director Robert Dickey IV resigns over disagreement with management on financial disclosures

## Summary
- Robert Dickey IV resigned from Emmaus board and audit committee effective Aug 4, 2022, citing disagreement with management.
- Management provided data showing improved monthly sales since Q4 2021/Q1 2022 and projections for growth and debt paydown.
- Dickey disagreed with the timeliness and adequacy of the information provided by management.
- The resignation letter is filed as Exhibit 99.1 to the 8-K.

## SEC filing metadata
- accession: 0001213900-22-046326
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2022-08-10T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390022046326/0001213900-22-046326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390022046326/ea164075-8k_emmaus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-046326
- JSON: https://secwatch.observer/filing/0001213900-22-046326.json
- Plain text: https://secwatch.observer/filing/0001213900-22-046326.txt

## Key facts
- Executive change
  Robert Dickey IV resigned as Director at Emmaus Life Sciences, Inc..
  - Action: resigned
  - Role: Director
  source text: By letter dated August 4, 2022, Robert Dickey IV resigned as a director of Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” or the “company”) over a disagreement with management of the company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/822370/000121390022046326/0001213900-22-046326-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
